Kane Biotech Inc Share Price Toronto S.E.
Equities
KNE
CA4838092084
Biotechnology & Medical Research
Sales 2022 | 2.67M 1.95M 156M | Sales 2023 | 149K 109K 8.7M | Capitalization | 10.55M 7.71M 616M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.19M -175M | Net income 2023 | -5M -3.65M -292M | EV / Sales 2022 | 6.37 x |
Net Debt 2022 | 5.76M 4.21M 336M | Net Debt 2023 | 8.51M 6.22M 497M | EV / Sales 2023 | 128 x |
P/E ratio 2022 |
-2.79
x | P/E ratio 2023 |
-2.02
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.07% |
Latest transcript on Kane Biotech Inc
Managers | Title | Age | Since |
---|---|---|---|
Marc Edwards
CEO | Chief Executive Officer | - | 01/06/16 |
Ray Dupuis
DFI | Director of Finance/CFO | - | 04/09/17 |
Compliance Officer | - | 11/08/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Renaud
BRD | Director/Board Member | - | 14/09/10 |
Chairman | 59 | 02-19 | |
Georges Morin
BRD | Director/Board Member | - | 19/05/20 |
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |